Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $1.13 Million - $1.48 Million
-4,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $1.04 Million - $1.66 Million
4,000 New
4,000 $1.39 Million
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $28.4 Million - $33.3 Million
-116,970 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $17.1 Million - $25.8 Million
72,434 Added 162.64%
116,970 $28.6 Million
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $15.7 Million - $18.1 Million
-59,366 Reduced 57.14%
44,536 $12.6 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $26.9 Million - $35.6 Million
103,902 New
103,902 $27.8 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $1.54 Million - $1.69 Million
-7,000 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $25.8 Million - $40.3 Million
-118,975 Reduced 94.44%
7,000 $1.66 Million
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $25.2 Million - $31.9 Million
90,441 Added 254.52%
125,975 $37.9 Million
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $34.2 Million - $44.7 Million
-116,568 Reduced 76.64%
35,534 $12.6 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $7.93 Million - $9.45 Million
-30,796 Reduced 16.84%
152,102 $44.1 Million
Q1 2018

May 15, 2018

BUY
$260.13 - $367.91 $47.6 Million - $67.3 Million
182,898 New
182,898 $50.1 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.